{"id":"W2165109429","doi":"10.1093/annonc/mdt536","title":"Phase II study of everolimus–erlotinib in previously treated patients with advanced non-small-cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Erlotinib; Medicine; Everolimus; Internal medicine; Lung cancer; Clinical endpoint; Oncology; Adverse effect; Phases of clinical research; Erlotinib Hydrochloride; Progressive disease; Cancer; Chemotherapy; Gastroenterology; Randomized controlled trial; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329587,0.00139483,0.002680152,0.0003138525,0.0004883615,0.001148152,0.0008183799,0.001296237,0.002921304],"category_scores_gemma":[0.0006136567,0.0007234605,0.001775453,0.0003308592,0.0009910492,0.001146532,0.0003683469,0.003800361,0.0009007913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008555092,"about_ca_system_score_gemma":0.001292281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001290796,"about_ca_topic_score_gemma":0.004215198,"domain_scores_codex":[0.9996008,0.0001682889,0.00002000059,0.00007923578,0.00002595356,0.0001056994],"domain_scores_gemma":[0.9994835,0.00007075322,0.00007527282,0.00004680318,0.00003150267,0.000292161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8055002,0.07133237,0.009939894,0.0006028108,0.002899424,0.0003717547,0.0002828032,0.003163412,0.03742578,0.0003314896,0.004632889,0.06351724],"study_design_scores_gemma":[0.6427013,0.3251964,0.02240496,0.00003280725,0.0008941046,0.000333654,0.0001106306,0.001337404,0.002771955,0.0002056651,0.003969927,0.00004107658],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943216,0.001817617,0.0003218165,0.0005693921,0.0001925538,0.0007943287,0.0006894679,0.00005165432,0.001241646],"genre_scores_gemma":[0.9890262,0.001844518,0.0009052038,0.0009989905,0.0002047848,0.001326257,0.002442614,0.00003072357,0.003220724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002921304,"threshold_uncertainty_score":0.009772778,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02761776305263436,"score_gpt":0.400648328946751,"score_spread":0.3730305658941166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}